Pneumococcal Vaccine Market Report

Global Pneumococcal Vaccine Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Jun 09, 2022
  • PAGES：175
  • REPORT CODE：GMM863082
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Pneumococcal Vaccine is the most effective means to prevent pneumonia, bacteremia and meningitis caused by pneumococcal bacteria.

    The global Pneumococcal Vaccine market value is expected to grow at a CAGR of 2% during the forecast period 2019-2026. According to the report, the market will be worth about $6.7 billion in 2019 and could grow to $7.9 billion by 2026.

    The increasing government efforts to make vaccinations available globally to raise awareness of vaccination programme and the increase in cases of pneumococcal disease caused by pathogens are expected to boost the market. The introduction of a pneumococcal vaccine with a broader serotype coverage, and the increasing support of governments and non-profit organizations for the supply, supply and distribution of pneumococcal vaccines in developing regions, are also expected to boost market growth.

    Pneumococcal Vaccine market report explains the definition, types, applications, major countries, and major players of the Pneumococcal Vaccine market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Pfizer

    • Sanofipasteur

    • CDIBP

    • GSK

    • MSD

    By Type:

    • Pneumococcal Polysaccharide Vaccines

    • Pneumococcal Conjugate Vaccines

    By End-User:

    • Child

    • Adult

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Pneumococcal Vaccine Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Pneumococcal Vaccine Outlook to 2028- Original Forecasts

    • 2.2 Pneumococcal Vaccine Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Pneumococcal Vaccine Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Pneumococcal Vaccine Market- Recent Developments

    • 6.1 Pneumococcal Vaccine Market News and Developments

    • 6.2 Pneumococcal Vaccine Market Deals Landscape

    7 Pneumococcal Vaccine Raw Materials and Cost Structure Analysis

    • 7.1 Pneumococcal Vaccine Key Raw Materials

    • 7.2 Pneumococcal Vaccine Price Trend of Key Raw Materials

    • 7.3 Pneumococcal Vaccine Key Suppliers of Raw Materials

    • 7.4 Pneumococcal Vaccine Market Concentration Rate of Raw Materials

    • 7.5 Pneumococcal Vaccine Cost Structure Analysis

      • 7.5.1 Pneumococcal Vaccine Raw Materials Analysis

      • 7.5.2 Pneumococcal Vaccine Labor Cost Analysis

      • 7.5.3 Pneumococcal Vaccine Manufacturing Expenses Analysis

    8 Global Pneumococcal Vaccine Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Pneumococcal Vaccine Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Pneumococcal Vaccine Export by Region (Top 10 Countries) (2017-2028)

    9 Global Pneumococcal Vaccine Market Outlook by Types and Applications to 2022

    • 9.1 Global Pneumococcal Vaccine Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Pneumococcal Polysaccharide Vaccines Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Pneumococcal Conjugate Vaccines Consumption and Growth Rate (2017-2022)

    • 9.2 Global Pneumococcal Vaccine Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Child Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Adult Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Pneumococcal Vaccine Market Analysis and Outlook till 2022

    • 10.1 Global Pneumococcal Vaccine Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Pneumococcal Vaccine Consumption (2017-2022)

      • 10.2.2 Canada Pneumococcal Vaccine Consumption (2017-2022)

      • 10.2.3 Mexico Pneumococcal Vaccine Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Pneumococcal Vaccine Consumption (2017-2022)

      • 10.3.2 UK Pneumococcal Vaccine Consumption (2017-2022)

      • 10.3.3 Spain Pneumococcal Vaccine Consumption (2017-2022)

      • 10.3.4 Belgium Pneumococcal Vaccine Consumption (2017-2022)

      • 10.3.5 France Pneumococcal Vaccine Consumption (2017-2022)

      • 10.3.6 Italy Pneumococcal Vaccine Consumption (2017-2022)

      • 10.3.7 Denmark Pneumococcal Vaccine Consumption (2017-2022)

      • 10.3.8 Finland Pneumococcal Vaccine Consumption (2017-2022)

      • 10.3.9 Norway Pneumococcal Vaccine Consumption (2017-2022)

      • 10.3.10 Sweden Pneumococcal Vaccine Consumption (2017-2022)

      • 10.3.11 Poland Pneumococcal Vaccine Consumption (2017-2022)

      • 10.3.12 Russia Pneumococcal Vaccine Consumption (2017-2022)

      • 10.3.13 Turkey Pneumococcal Vaccine Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Pneumococcal Vaccine Consumption (2017-2022)

      • 10.4.2 Japan Pneumococcal Vaccine Consumption (2017-2022)

      • 10.4.3 India Pneumococcal Vaccine Consumption (2017-2022)

      • 10.4.4 South Korea Pneumococcal Vaccine Consumption (2017-2022)

      • 10.4.5 Pakistan Pneumococcal Vaccine Consumption (2017-2022)

      • 10.4.6 Bangladesh Pneumococcal Vaccine Consumption (2017-2022)

      • 10.4.7 Indonesia Pneumococcal Vaccine Consumption (2017-2022)

      • 10.4.8 Thailand Pneumococcal Vaccine Consumption (2017-2022)

      • 10.4.9 Singapore Pneumococcal Vaccine Consumption (2017-2022)

      • 10.4.10 Malaysia Pneumococcal Vaccine Consumption (2017-2022)

      • 10.4.11 Philippines Pneumococcal Vaccine Consumption (2017-2022)

      • 10.4.12 Vietnam Pneumococcal Vaccine Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Pneumococcal Vaccine Consumption (2017-2022)

      • 10.5.2 Colombia Pneumococcal Vaccine Consumption (2017-2022)

      • 10.5.3 Chile Pneumococcal Vaccine Consumption (2017-2022)

      • 10.5.4 Argentina Pneumococcal Vaccine Consumption (2017-2022)

      • 10.5.5 Venezuela Pneumococcal Vaccine Consumption (2017-2022)

      • 10.5.6 Peru Pneumococcal Vaccine Consumption (2017-2022)

      • 10.5.7 Puerto Rico Pneumococcal Vaccine Consumption (2017-2022)

      • 10.5.8 Ecuador Pneumococcal Vaccine Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Pneumococcal Vaccine Consumption (2017-2022)

      • 10.6.2 Kuwait Pneumococcal Vaccine Consumption (2017-2022)

      • 10.6.3 Oman Pneumococcal Vaccine Consumption (2017-2022)

      • 10.6.4 Qatar Pneumococcal Vaccine Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Pneumococcal Vaccine Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Pneumococcal Vaccine Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Pneumococcal Vaccine Consumption (2017-2022)

      • 10.7.2 South Africa Pneumococcal Vaccine Consumption (2017-2022)

      • 10.7.3 Egypt Pneumococcal Vaccine Consumption (2017-2022)

      • 10.7.4 Algeria Pneumococcal Vaccine Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Pneumococcal Vaccine Consumption (2017-2022)

      • 10.8.2 New Zealand Pneumococcal Vaccine Consumption (2017-2022)

    11 Global Pneumococcal Vaccine Competitive Analysis

    • 11.1 Pfizer

      • 11.1.1 Pfizer Company Details

      • 11.1.2 Pfizer Pneumococcal Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Pfizer Pneumococcal Vaccine Main Business and Markets Served

      • 11.1.4 Pfizer Pneumococcal Vaccine Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Sanofipasteur

      • 11.2.1 Sanofipasteur Company Details

      • 11.2.2 Sanofipasteur Pneumococcal Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Sanofipasteur Pneumococcal Vaccine Main Business and Markets Served

      • 11.2.4 Sanofipasteur Pneumococcal Vaccine Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 CDIBP

      • 11.3.1 CDIBP Company Details

      • 11.3.2 CDIBP Pneumococcal Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 CDIBP Pneumococcal Vaccine Main Business and Markets Served

      • 11.3.4 CDIBP Pneumococcal Vaccine Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 GSK

      • 11.4.1 GSK Company Details

      • 11.4.2 GSK Pneumococcal Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 GSK Pneumococcal Vaccine Main Business and Markets Served

      • 11.4.4 GSK Pneumococcal Vaccine Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 MSD

      • 11.5.1 MSD Company Details

      • 11.5.2 MSD Pneumococcal Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 MSD Pneumococcal Vaccine Main Business and Markets Served

      • 11.5.4 MSD Pneumococcal Vaccine Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    12 Global Pneumococcal Vaccine Market Outlook by Types and Applications to 2028

    • 12.1 Global Pneumococcal Vaccine Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Pneumococcal Polysaccharide Vaccines Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Pneumococcal Conjugate Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Pneumococcal Vaccine Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Child Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Adult Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Pneumococcal Vaccine Market Analysis and Outlook to 2028

    • 13.1 Global Pneumococcal Vaccine Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Pneumococcal Vaccine Consumption Forecast (2022-2028)

      • 13.2.2 Canada Pneumococcal Vaccine Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Pneumococcal Vaccine Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Pneumococcal Vaccine Consumption Forecast (2022-2028)

      • 13.3.2 UK Pneumococcal Vaccine Consumption Forecast (2022-2028)

      • 13.3.3 Spain Pneumococcal Vaccine Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Pneumococcal Vaccine Consumption Forecast (2022-2028)

      • 13.3.5 France Pneumococcal Vaccine Consumption Forecast (2022-2028)

      • 13.3.6 Italy Pneumococcal Vaccine Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Pneumococcal Vaccine Consumption Forecast (2022-2028)

      • 13.3.8 Finland Pneumococcal Vaccine Consumption Forecast (2022-2028)

      • 13.3.9 Norway Pneumococcal Vaccine Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Pneumococcal Vaccine Consumption Forecast (2022-2028)

      • 13.3.11 Poland Pneumococcal Vaccine Consumption Forecast (2022-2028)

      • 13.3.12 Russia Pneumococcal Vaccine Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Pneumococcal Vaccine Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Pneumococcal Vaccine Consumption Forecast (2022-2028)

      • 13.4.2 Japan Pneumococcal Vaccine Consumption Forecast (2022-2028)

      • 13.4.3 India Pneumococcal Vaccine Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Pneumococcal Vaccine Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Pneumococcal Vaccine Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Pneumococcal Vaccine Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Pneumococcal Vaccine Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Pneumococcal Vaccine Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Pneumococcal Vaccine Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Pneumococcal Vaccine Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Pneumococcal Vaccine Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Pneumococcal Vaccine Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Pneumococcal Vaccine Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Pneumococcal Vaccine Consumption Forecast (2022-2028)

      • 13.5.3 Chile Pneumococcal Vaccine Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Pneumococcal Vaccine Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Pneumococcal Vaccine Consumption Forecast (2022-2028)

      • 13.5.6 Peru Pneumococcal Vaccine Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Pneumococcal Vaccine Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Pneumococcal Vaccine Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Pneumococcal Vaccine Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Pneumococcal Vaccine Consumption Forecast (2022-2028)

      • 13.6.3 Oman Pneumococcal Vaccine Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Pneumococcal Vaccine Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Pneumococcal Vaccine Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Pneumococcal Vaccine Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Pneumococcal Vaccine Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Pneumococcal Vaccine Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Pneumococcal Vaccine Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Pneumococcal Vaccine Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Pneumococcal Vaccine Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Pneumococcal Vaccine Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Pneumococcal Vaccine

    • Figure of Pneumococcal Vaccine Picture

    • Table Global Pneumococcal Vaccine Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Pneumococcal Vaccine Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Pneumococcal Polysaccharide Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global Pneumococcal Conjugate Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global Child Consumption and Growth Rate (2017-2022)

    • Figure Global Adult Consumption and Growth Rate (2017-2022)

    • Figure Global Pneumococcal Vaccine Consumption by Country (2017-2022)

    • Table North America Pneumococcal Vaccine Consumption by Country (2017-2022)

    • Figure United States Pneumococcal Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Canada Pneumococcal Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Mexico Pneumococcal Vaccine Consumption and Growth Rate (2017-2022)

    • Table Europe Pneumococcal Vaccine Consumption by Country (2017-2022)

    • Figure Germany Pneumococcal Vaccine Consumption and Growth Rate (2017-2022)

    • Figure UK Pneumococcal Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Spain Pneumococcal Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Belgium Pneumococcal Vaccine Consumption and Growth Rate (2017-2022)

    • Figure France Pneumococcal Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Italy Pneumococcal Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Denmark Pneumococcal Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Finland Pneumococcal Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Norway Pneumococcal Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Sweden Pneumococcal Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Poland Pneumococcal Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Russia Pneumococcal Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Turkey Pneumococcal Vaccine Consumption and Growth Rate (2017-2022)

    • Table APAC Pneumococcal Vaccine Consumption by Country (2017-2022)

    • Figure China Pneumococcal Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Japan Pneumococcal Vaccine Consumption and Growth Rate (2017-2022)

    • Figure India Pneumococcal Vaccine Consumption and Growth Rate (2017-2022)

    • Figure South Korea Pneumococcal Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Pneumococcal Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Pneumococcal Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Pneumococcal Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Thailand Pneumococcal Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Singapore Pneumococcal Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Pneumococcal Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Philippines Pneumococcal Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Pneumococcal Vaccine Consumption and Growth Rate (2017-2022)

    • Table South America Pneumococcal Vaccine Consumption by Country (2017-2022)

    • Figure Brazil Pneumococcal Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Colombia Pneumococcal Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Chile Pneumococcal Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Argentina Pneumococcal Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Pneumococcal Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Peru Pneumococcal Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Pneumococcal Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Pneumococcal Vaccine Consumption and Growth Rate (2017-2022)

    • Table GCC Pneumococcal Vaccine Consumption by Country (2017-2022)

    • Figure Bahrain Pneumococcal Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Pneumococcal Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Oman Pneumococcal Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Qatar Pneumococcal Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Pneumococcal Vaccine Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Pneumococcal Vaccine Consumption and Growth Rate (2017-2022)

    • Table Africa Pneumococcal Vaccine Consumption by Country (2017-2022)

    • Figure Nigeria Pneumococcal Vaccine Consumption and Growth Rate (2017-2022)

    • Figure South Africa Pneumococcal Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Egypt Pneumococcal Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Algeria Pneumococcal Vaccine Consumption and Growth Rate (2017-2022)

    • Table Oceania Pneumococcal Vaccine Consumption by Country (2017-2022)

    • Figure Australia Pneumococcal Vaccine Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Pneumococcal Vaccine Consumption and Growth Rate (2017-2022)

    • Table Pfizer Company Details

    • Table Pfizer Pneumococcal Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Pneumococcal Vaccine Main Business and Markets Served

    • Table Pfizer Pneumococcal Vaccine Product Portfolio

    • Table Sanofipasteur Company Details

    • Table Sanofipasteur Pneumococcal Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofipasteur Pneumococcal Vaccine Main Business and Markets Served

    • Table Sanofipasteur Pneumococcal Vaccine Product Portfolio

    • Table CDIBP Company Details

    • Table CDIBP Pneumococcal Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table CDIBP Pneumococcal Vaccine Main Business and Markets Served

    • Table CDIBP Pneumococcal Vaccine Product Portfolio

    • Table GSK Company Details

    • Table GSK Pneumococcal Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table GSK Pneumococcal Vaccine Main Business and Markets Served

    • Table GSK Pneumococcal Vaccine Product Portfolio

    • Table MSD Company Details

    • Table MSD Pneumococcal Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table MSD Pneumococcal Vaccine Main Business and Markets Served

    • Table MSD Pneumococcal Vaccine Product Portfolio

    • Figure Global Pneumococcal Polysaccharide Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pneumococcal Conjugate Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Child Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Adult Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pneumococcal Vaccine Consumption Forecast by Country (2022-2028)

    • Table North America Pneumococcal Vaccine Consumption Forecast by Country (2022-2028)

    • Figure United States Pneumococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Pneumococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Pneumococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Pneumococcal Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Germany Pneumococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Pneumococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Pneumococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Pneumococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Pneumococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Pneumococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Pneumococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Pneumococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Pneumococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Pneumococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Pneumococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Pneumococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Pneumococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Pneumococcal Vaccine Consumption Forecast by Country (2022-2028)

    • Figure China Pneumococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Pneumococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Pneumococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Pneumococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Pneumococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Pneumococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Pneumococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Pneumococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Pneumococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Pneumococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Pneumococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Pneumococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Pneumococcal Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Brazil Pneumococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Pneumococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Pneumococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Pneumococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Pneumococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Pneumococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Pneumococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Pneumococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Pneumococcal Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Pneumococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Pneumococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Pneumococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Pneumococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Pneumococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Pneumococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Pneumococcal Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Pneumococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Pneumococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Pneumococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Pneumococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Pneumococcal Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Australia Pneumococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Pneumococcal Vaccine Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US